Success Stories
Powered by Likarda

See how our encapsulation and delivery platforms are driving measurable impact and creating real-world results across a range of therapeutic applications.

Antibodies (NovoSphere™)
Monthly mAb dosing achieved through lyophilized, extended-release formulation. 
Read Success Story
Osteoarthritis Therapy (ViscoCell™)
Stem cell delivery improved joint retention and drove cartilage repair in osteoarthritis.
Read Success Story
Diabetes Treatment (EnduraCell™)
Sustained blood glucose control without daily insulin injections in preclinical models.
Read Success Story
Cryopreservation (LiberaCell™)
Fragile liver spheroids survive freezing with full function restored.
Read Success Story
Liver Disease (EnduraCell™)
30-day functional liver spheroids outperforming alginate models. 
Read Success Story
CAR-T Cells (VitaCell™)
Encapsulation enabled controlled, localized release of CAR-T cells in glioblastoma, dramatically improving persistence and metabolic activity compared to unencapsulated controls.
Read Success Story
Cryopreservation (AegisCell™)
T-cells stayed viable and functional for 2 weeks on dry ice, matching LN2 storage.
Read Success Story
Extending the Life of Fresh Cells (LiberaCell™)
Fragile liver spheroids survive freezing with full function restored.
Read Success Story
Preserving Islet Viability with Cryopreservation (LiberaCell™)
High viability is maintained for fragile islets used in diabetes research and future transplant applications.
Read Success Story